Investor mix
7 investors on record; lead investors include Remiges Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 71% |
| Accelerator & incubator | 1 | 14% |
| Other / undisclosed | 1 | 14% |
Small molecule inhibitors targeting a novel pathway to treat malignant melanoma
7 investors on record; lead investors include Remiges Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 71% |
| Accelerator & incubator | 1 | 14% |
| Other / undisclosed | 1 | 14% |